| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | Aug 13, 2025 | MAXCYTE, INC. | CFO | Buy | 95.0 | +50,000 | 44.72% | ✗ | $64.5K |
| Mar 18, 2025 | Mar 20, 2025 | MAXCYTE, INC. | CFO | Sell | 46.3 | -6,939 | -5.84% | ✗ | $22.1K |
| Sep 14, 2021 | Sep 14, 2021 | Cellectar Biosciences, Inc. | Director | Buy | 91.3 | +25,000 | 100.00% | ✗ | $26K |
| Jan 29, 2019 | Jan 30, 2019 | Opus Genetics, Inc. | CEO | Buy | 91.3 | +50,000 | 100.00% | ✗ | $31.7K |